Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Olle Ringdén

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Living Beings

Concepts & Ideas

Phenomena

Recurrence

Anatomy

T-Lymphocytes

Chemicals & Drugs

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Ringdén Olle; Karlsson Helen; Olsson Richard; Omazic Brigitta; Uhlin Michael
The allogeneic graft-versus-cancer effect.
Ringdén Olle
Mesenchymal stromal cells as first-line treatment of graft failure after hematopoietic stem cell transplantation.
Marks David I; Ballen Karen; Logan Brent R; Wang Zhiwei; Sobocinski Kathleen A; Bacigalupo Andrea; Burns Linda J; Gupta Vikas; Ho Vincent; McCarthy Philip L; Ringdén Olle; Schouten Harry C; Seftel Matthew; Rizzo J Douglas
The effect of smoking on allogeneic transplant outcomes.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Olle Ringdén (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Ringdén Olle; Karlsson Helen; Olsson Richard; Omazic Brigitta; Uhlin Michael
The allogeneic graft-versus-cancer effect.
British journal of haematology 2009;147(5):614-33.
2009: Ringdén Olle
Mesenchymal stromal cells as first-line treatment of graft failure after hematopoietic stem cell transplantation.
Stem cells and development 2009;18(9):1243-6.
2009: Marks David I; Ballen Karen; Logan Brent R; Wang Zhiwei; Sobocinski Kathleen A; Bacigalupo Andrea; Burns Linda J; Gupta Vikas; Ho Vincent; McCarthy Philip L; Ringdén Olle; Schouten Harry C; Seftel Matthew; Rizzo J Douglas
The effect of smoking on allogeneic transplant outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(10):1277-87.
2009: Omar H; Hägglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringdén O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
Transplant infectious disease : an official journal of the Transplantation Society 2009;11(5):393-9.
2009: Le Blanc Katarina; Barrett A John; Schaffer Marie; Hägglund Hans; Ljungman Per; Ringdén Olle; Remberger Mats
Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(9):1108-15.
2009: Ringdén Olle; Labopin Myriam; Ehninger Gerhard; Niederwieser Dietger; Olsson Richard; Basara Nadezda; Finke Juergen; Schwerdtfeger Rainer; Eder Matthias; Bunjes Donald; Gorin Norbert-Claude; Mohty Mohamad; Rocha Vanderson
Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(27):4570-7.
2009: Sundin Mikael; Barrett A John; Ringdén Olle; Uzunel Mehmet; Lönnies Helena; Dackland Asa-Lena; Christensson Birger; Blanc Katarina Le
HSCT recipients have specific tolerance to MSC but not to the MSC donor.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(7):755-64.
2009: Ringdén Olle; Karlsson Helen; Omazic Brigitta
Immune reconstitution after HLA mismatched haemopoietic stem-cell transplantation.
The lancet oncology 2009;10(5):440-2.
2009: Benden Christian; Dipchand Anne I; Danziger-Isakov Lara A; Esquivel Carlos O; Ringdén Olle; Wray Jo; Marks Stephen D
Pediatric transplantation: ten years on.
Pediatric transplantation 2009;13(3):272-7.
2009: Aglietta Massimo; Barkholt Lisbeth; Schianca Fabrizio Carnevale; Caravelli Daniela; Omazic Brigitta; Minotto Coludia; Leone Francesco; Hentschke Patrik; Bertoldero Giovanni; Capaldi Antonio; Ciccone Giovannino; Niederwieser Dietger; Ringdén Olle; Demirer Tanner;
Reduced-intensity allogeneic hematopoietic stem cell transplantation in metastatic colorectal cancer as a novel adoptive cell therapy approach. The European group for blood and marrow transplantation experience.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(3):326-35.
2009: Uhlin Michael; Okas Mantas; Karlsson Helen; Gertow Jens; Henningsohn Lars; Ringdén Olle; Kärre Klas; Levitsky Victor; Mattsson Jonas
Increased frequency and responsiveness of PSA-specific T cells after allogeneic hematopoetic stem-cell transplantation.
Transplantation 2009;87(4):467-72.
2009: Samuelsson H; Ringdén O; Lönnies H; Le Blanc K
Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells.
Cytotherapy 2009;11(2):129-36.
2008: Malm Gunilla; von Döbeln Ulrika; Naess Karin; Ringdén Olle
[Progress on lysosomal diseases yields hope for cure and improvement]
Läkartidningen 2008;105(51-52):3731-5.
2008: Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström A-C; Remberger M
Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
Tissue antigens 2008;72(6):549-58.
2008: Hahn Theresa; McCarthy Philip L; Zhang Mei-Jie; Wang Dan; Arora Mukta; Frangoul Haydar; Gale Robert Peter; Hale Gregory A; Horan John; Isola Luis; Maziarz Richard T; van Rood Jon J; Gupta Vikas; Halter Joerg; Reddy Vijay; Tiberghien Pierre; Litzow Mark; Anasetti Claudio; Pavletic Stephen; Ringdén Olle
Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(35):5728-34.
2008: Ringdén O; Okas M; Uhlin M; Uzunel M; Remberger M; Mattsson J
Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor.
Bone marrow transplantation 2008;42(10):643-8.
2008: Malm Gunilla; Gustafsson Britt; Berglund Gunilla; Lindström Maria; Naess Karin; Borgström Birgit; von Döbeln Ulrika; Ringdén Olle
Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT).
Acta paediatrica (Oslo, Norway : 1992) 2008;97(8):1108-12.
2008: Karlsson Helen; Samarasinghe Sujith; Ball Lynne M; Sundberg Berit; Lankester Arjan C; Dazzi Francesco; Uzunel Mehmet; Rao Kanchan; Veys Paul; Le Blanc Katarina; Ringdén Olle; Amrolia Persis J
Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses.
Blood 2008;112(3):532-41.
2008: Sairafi D; Uzunel M; Remberger M; Ringdén O; Mattsson J
No impact of NOD2/CARD15 on outcome after SCT.
Bone marrow transplantation 2008;41(11):961-4.
2008: Le Blanc Katarina; Frassoni Francesco; Ball Lynne; Locatelli Franco; Roelofs Helene; Lewis Ian; Lanino Edoardo; Sundberg Berit; Bernardo Maria Ester; Remberger Mats; Dini Giorgio; Egeler R Maarten; Bacigalupo Andrea; Fibbe Willem; Ringdén Olle;
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.
Lancet 2008;371(9624):1579-86.
2008: Edvinsson Benjamin; Lundquist Jessica; Ljungman Per; Ringdén Olle; Evengård Birgitta
A prospective study of diagnosis of Toxoplasma gondii infection after bone marrow transplantation.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2008;116(5):345-51.
2008: Remberger Mats; Mattsson Jonas; Hausenberger Dan; Schaffer Marie; Svahn Britt-Marie; Ringdén Olle
Genomic tissue typing and optimal antithymocyte globuline dose using unrelated donors results in similar survival and relapse as HLA-identical siblings in haematopoietic stem-cell transplantation for leukaemia.
European journal of haematology 2008;80(5):419-28.
2008: Barkholt L; Remberger M; Hassan Z; Fransson K; Omazic B; Svahn B-M; Karlsson H; Brune M; Hassan M; Mattsson J; Ringdén O
A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2008;41(9):785-90.
2008: Svahn Britt-Marie; Remberger Mats; Heijbel Mona; Martell Eva; Wikström Marie; Eriksson Britta; Milovsavljevic Ruza; Mattsson Jonas; Ringdén Olle
Case-control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutrition.
Transplantation 2008;85(7):1000-7.
2008: Conrad Réka; Remberger Mats; Cederlund Kerstin; Ringdén Olle; Barkholt Lisbeth
A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.
Haematologica 2008;93(2):265-72.
2008: Norlin A-C; Sairafi D; Mattsson J; Ljungman P; Ringdén O; Remberger M
Allogeneic stem cell transplantation: low immunoglobulin levels associated with decreased survival.
Bone marrow transplantation 2008;41(3):267-73.
2008: Remberger M; Mattsson J; Hassan Z; Karlsson N; LeBlanc K; Omazic B; Okas M; Sairafi D; Ringdén O
Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors: a single centre study.
Bone marrow transplantation 2008;41(4):399-405.
2008: Mattsson Jonas; Ringdén Olle; Storb Rainer
Graft failure after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(1 Suppl 1):165-70.
2008: Sundin M; Remberger M; Lönnies H; Sundberg B; Ringdén O; Le Blanc K
No increased trapping of multipotent mesenchymal stromal cells in bone marrow filters compared with other bone marrow cells.
Cytotherapy 2008;10(3):238-42.
2007: Shaw Bronwen E; Gooley Theodore A; Malkki Mari; Madrigal J Alejandro; Begovich Ann B; Horowitz Mary M; Gratwohl Alois; Ringdén Olle; Marsh Steven G E; Petersdorf Effie W
The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation.
Blood 2007;110(13):4560-6.
2007: Le Blanc K; Ringdén O
Immunomodulation by mesenchymal stem cells and clinical experience.
Journal of internal medicine 2007;262(5):509-25.
2007: Avetisyan G; Aschan J; Hägglund H; Ringdén O; Ljungman P
Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT.
Bone marrow transplantation 2007;40(9):865-9.
2007: Januszkiewicz Anna; Klaude Maria; Loré Karin; Andersson Jan; Ringdén Olle; Rooyackers Olav; Wernerman Jan
Enhanced in vivo protein synthesis in circulating immune cells of ICU patients.
Journal of clinical immunology 2007;27(6):589-97.
2007: Ringdén O; Uzunel M; Sundberg B; Lönnies L; Nava S; Gustafsson J; Henningsohn L; Le Blanc K
Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(11):2271-6.
2007: Le Blanc Katarina; Samuelsson Håkan; Lönnies Lena; Sundin Mikael; Ringdén Olle
Generation of immunosuppressive mesenchymal stem cells in allogeneic human serum.
Transplantation 2007;84(8):1055-9.
2007: Barkholt L; Remberger M; Bodegård H; Ringdén O; Böttiger Y
Cyclosporine A (CsA) 2-h concentrations vary between patients without correlation to graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Bone marrow transplantation 2007;40(7):683-9.
2007: Hassan Zuzana; Remberger Mats; Svenberg Petter; Elbander Maria; Omazic Brigitta; Mattsson Jonas; Conrad Réka; Svahn Britt-Marie; Ahlgren Anders; Sairafi Darius; Aschan Johan; Le Blanc Katarina; Barkholt Lisbeth; Ringdén Olle
Hemorrhagic cystitis: a retrospective single-center survey.
Clinical transplantation 2007;21(5):659-67.
2007: Sundin Mikael; Ringdén Olle; Sundberg Berit; Nava Silvia; Götherström Cecilia; Le Blanc Katarina
No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients.
Haematologica 2007;92(9):1208-15.
2007: Remberger Mats; Ringdén Olle
Similar outcome after unrelated allogeneic peripheral blood stem cell transplantation compared with bone marrow in children and adolescents.
Transplantation 2007;84(4):551-4.
2007: Le Blanc K; Samuelsson H; Gustafsson B; Remberger M; Sundberg B; Arvidson J; Ljungman P; Lönnies H; Nava S; Ringdén O
Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(8):1733-8.
2007: Remberger Mats; Watz Emma; Ringdén Olle; Mattsson Jonas; Shanwell Agneta; Wikman Agneta
Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(6):675-82.
2007: Rasmusson I; Le Blanc K; Sundberg B; Ringdén O
Mesenchymal stem cells stimulate antibody secretion in human B cells.
Scandinavian journal of immunology 2007;65(4):336-43.
2007: Ringdén O; Remberger M; Svenberg P; Svahn B-M; Dahllöf G; Gustafsson B; Hassan Z; Omazic B; Uzunel M; Aschan J; Barkholt L; Winiarski J; Ljungman P; Mattsson J
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases.
Bone marrow transplantation 2007;39(7):383-8.
2007: Bågesund Mats; Richter Sven; Ringdén Olle; Dahllöf Göran
Longitudinal scintigraphic study of parotid and submandibular gland function after total body irradiation in children and adolescents.
International journal of paediatric dentistry / the British Paedodontic Society [and] the International Association of Dentistry for Children 2007;17(1):34-40.
2007: Ringdén Olle
Immunotherapy by allogeneic stem cell transplantation.
Advances in cancer research 2007;97():25-60.
2006: Uzunel Mehmet; Remberger Mats; Sairafi Darius; Hassan Zuzana; Mattsson Jonas; Omazic Brigitta; Barkholt Lisbeth; Ringdén Olle
Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning.
Transplantation 2006;82(7):913-9.
2006: Le Blanc Katarina; Ringdén Olle
Mesenchymal stem cells: properties and role in clinical bone marrow transplantation.
Current opinion in immunology 2006;18(5):586-91.
2006: Sundin Mikael; Le Blanc Katarina; Ringdén Olle; Barkholt Lisbeth; Omazic Brigitta; Lergin Christina; Levitsky Victor; Remberger Mats
The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.
Haematologica 2006;91(8):1059-67.
2006: Ringdén O; Svenberg P; Le Blanc K; Mattsson J; Remberger M
Myeloablative conditioning for hematopoietic stem-cell transplantation in patients with non-malignant diseases.
Bone marrow transplantation 2006;38(4):321-2.
2006: Svahn Britt-Marie; Alvin Ole; Ringdén Olle; Gardulf Ann; Remberger Mats
Costs of allogeneic hematopoietic stem cell transplantation.
Transplantation 2006;82(2):147-53.
2006: Svahn Britt-Marie; Ringdén Olle; Remberger Mats
Treatment costs and survival in patients with grades III-IV acute graft-versus-host disease after allogenic hematopoietic stem cell transplantation during three decades.
Transplantation 2006;81(11):1600-3.
2006: Ringdén Olle; Le Blanc Katarina
Mesenchymal stem cells combined with cyclosporine inhibits cytotoxic T cells.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(6):693-4.
2006: Sundin M; Orvell C; Rasmusson I; Sundberg B; Ringdén O; Le Blanc K
Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual.
Bone marrow transplantation 2006;37(11):1051-9.
2006: Ringdén Olle; Uzunel Mehmet; Rasmusson Ida; Remberger Mats; Sundberg Berit; Lönnies Helena; Marschall Hanns-Ulrich; Dlugosz Aldona; Szakos Attila; Hassan Zuzana; Omazic Brigitta; Aschan Johan; Barkholt Lisbeth; Le Blanc Katarina
Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.
Transplantation 2006;81(10):1390-7.
2006: Ringdén Olle; Remberger Mats; Svahn Britt-Marie; Barkholt Lisbeth; Mattsson Jonas; Aschan Johan; Le Blanc Katarina; Gustafsson Britt; Hassan Zuzana; Omazic Brigitta; Svenberg Petter; Solders Göran; von Döbeln Ulrika; Winiarski Jacek; Ljungman Per; Malm Gunilla
Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center.
Transplantation 2006;81(5):718-25.
2006: Conrad Réka; Remberger Mats; Cederlund Kerstin; Hentschke Patrik; Sundberg Berit; Ringdén Olle; Barkholt Lisbeth
Inflammatory cytokines predominate in cases of tumor regression after hematopoietic stem cell transplantation for solid cancer.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(3):346-54.
2006: Khoury Hanna J; Loberiza Fausto R; Ringdén Olle; Barrett A John; Bolwell Brian J; Cahn Jean-Yves; Champlin Richard E; Gale Robert Peter; Hale Gregory A; Urbano-Ispizua Alvaro; Martino Rodrigo; McCarthy Philip L; Tiberghien Pierre; Verdonck Leo F; Horowitz Mary M
Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation.
Blood 2006;107(4):1712-6.
2006: Ljungman Per; Perez-Bercoff Lena; Jonsson Jerker; Avetisyan Gayane; Sparrelid Elda; Aschan Johan; Barkholt Lisbeth; Larsson Kajsa; Winiarski Jacek; Yun Zhibing; Ringdén Olle
Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation.
Haematologica 2006;91(1):78-83.
2005: Seebach Jörg D; Stussi Georg; Passweg Jakob R; Loberiza Fausto R; Gajewski James L; Keating Armand; Goerner Martin; Rowlings Philip A; Tiberghien Pierre; Elfenbein Gerald J; Gale Robert Peter; van Rood Jon J; Reddy Vijay; Gluckman Eliane; Bolwell Brian J; Klumpp Thomas R; Horowitz Mary M; Ringdén Olle; Barrett A John;
ABO blood group barrier in allogeneic bone marrow transplantation revisited.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(12):1006-13.
2005: Ringdén Olle; Le Blanc Katarina
Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2005;113(11-12):813-30.
2005: Svahn B M; Ringdén O; Remberger M
Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation.
Bone marrow transplantation 2005;36(6):511-6.
2005: Pavletic Steven Z; Khouri Issa F; Haagenson Michael; King Roberta J; Bierman Philip J; Bishop Michael R; Carston Michael; Giralt Sergio; Molina Arturo; Copelan Edward A; Ringdén Olle; Roy Vivek; Ballen Karen; Adkins Douglas R; McCarthy Philip; Weisdorf Daniel; Montserrat Emili; Anasetti Claudio
Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: results from the Center for International Blood and Marrow Transplant research.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5788-94.
2005: Diedrich Beatrice; Remberger Mats; Shanwell Agneta; Svahn Britt-Marie; Ringdén Olle
A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients.
Transfusion 2005;45(7):1064-72.
2005: Le Blanc Katarina; Götherström Cecilia; Ringdén Olle; Hassan Moustapha; McMahon Robert; Horwitz Edwin; Anneren Göran; Axelsson Ove; Nunn Janice; Ewald Uwe; Nordén-Lindeberg Solveig; Jansson Monika; Dalton Ann; Aström Eva; Westgren Magnus
Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta.
Transplantation 2005;79(11):1607-14.
2005: Le Blanc Katarina; Ringdén Olle
Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(5):321-34.
2005: Le Blanc Katarina; Ringdén Olle
Use of mesenchymal stem cells for the prevention of immune complications of hematopoietic stem cell transplantation.
Haematologica 2005;90(4):438.
2005: Rasmusson Ida; Ringdén Olle; Sundberg Berit; Le Blanc Katarina
Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms.
Experimental cell research 2005;305(1):33-41.
2005: Hentschke P; Omazic B; Mattsson J; Näsman-Björk I; Lundkvist I; Gigliotti D; Barkholt L; Ringdén O; Remberger M
T-cell receptor Vbeta repertoire after myeloablative and reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.
Scandinavian journal of immunology 2005;61(3):285-94.
2005: Ringdén Olle
Introduction to graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(2 Suppl 2):17-20.
2005: Malmberg Karl-Johan; Schaffer Marie; Ringdén Olle; Remberger Mats; Ljunggren Hans-Gustaf
KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation.
Molecular immunology 2005;42(4):531-4.
2005: Januszkiewicz Anna; Klaude Maria; Loré Karin; Andersson Jan; Ringdén Olle; Rooyackers Olav; Wernerman Jan
Determination of in vivo protein synthesis in human palatine tonsil.
Clinical science (London, England : 1979) 2005;108(2):179-84.
2005: Oh Hakumei; Loberiza Fausto R; Zhang Mei-jie; Ringdén Olle; Akiyama Hideki; Asai Takayoshi; Miyawaki Shuichi; Okamoto Shinichiro; Horowitz Mary M; Antin Joseph H; Bashey Asad; Bird Jennifer M; Carabasi Matthew H; Fay Joseph W; Gale Robert Peter; Giller Roger H; Goldman John M; Hale Gregory A; Harris Richard E; Henslee-Downey Jean; Kolb Hans-Jochem; Litzow Mark R; McCarthy Philip L; Neudorf Steven M; Serna Derek S; Socié Gerard; Tiberghien Pierre; Barrett A John
Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations.
Blood 2005;105(4):1408-16.
2005: Békássy Albert N; Ringdén Olle; Juliusson Gunnar; Winiarski Jacek
[Collection of fetal blood should be publicly financed]
Läkartidningen 2005;102(1-2):64.
2005: Omazic B; Hentschke P; Näsman-Björk I; Mattsson J; Oxelius V-A; Ringdén O; Barkholt L; Permert J; Lundkvist I
Reconstitution of the Ig heavy chain CDR3 repertoire after allogeneic haematopoietic stem cell transplantation with myeloablative or reduced-intensity conditioning regimens.
Scandinavian journal of immunology 2005;61(1):72-81.
2005: Remberger Mats; Beelen Dietrich W; Fauser Axel; Basara Nadezda; Basu Oliver; Ringdén Olle
Increased risk of extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation using unrelated donors.
Blood 2005;105(2):548-51.
2004: Svenberg Petter; Remberger Mats; Svennilson Johan; Mattsson Jonas; Leblanc Katarina; Gustafsson Britt; Aschan Johan; Barkholt Lisbeth; Winiarski Jacek; Ljungman Per; Ringdén Olle
Allogenic stem cell transplantation for nonmalignant disorders using matched unrelated donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(12):877-82.
2004: Eapen Mary; Horowitz Mary M; Klein John P; Champlin Richard E; Loberiza Fausto R; Ringdén Olle; Wagner John E
Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(24):4872-80.
2004: Ljungman P; Aschan J; Gustafsson B; Lewensohn-Fuchs I; Winiarski J; Ringdén O
Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients.
Bone marrow transplantation 2004;34(12):1067-9.
2004: Schaffer Marie; Malmberg Karl-Johan; Ringdén Olle; Ljunggren Hans-Gustaf; Remberger Mats
Increased infection-related mortality in KIR-ligand-mismatched unrelated allogeneic hematopoietic stem-cell transplantation.
Transplantation 2004;78(7):1081-5.
2004: Le Blanc Katarina; Remberger Mats; Uzunel Mehmet; Mattsson Jonas; Barkholt Lisbeth; Ringdén Olle
A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation.
Transplantation 2004;78(7):1014-20.
2004: Gustafsson Jernberg Asa; Remberger Mats; Ringdén Olle; Winiarski Jacek
Risk factors in pediatric stem cell transplantation for leukemia.
Pediatric transplantation 2004;8(5):464-74.
2004: Eapen M; Giralt S A; Horowitz M M; Klein J P; Wagner J E; Zhang M-J; Tallman M S; Marks D I; Camitta B M; Champlin R E; Ringdén O; Bredeson C N; Martino R; Gale R P; Cairo M S; Litzow M R; deLima M
Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.
Bone marrow transplantation 2004;34(8):721-7.
2004: Ljungman P; Aschan J; Barkholt L; Broliden P-A; Gustafsson B; Lewensohn-Fuchs I; Löfgren C; Winiarski J; Ringdén O
Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease.
Bone marrow transplantation 2004;34(7):589-93.
2004: Barkholt Lisbeth; Danielsson Rimma; Calissendorff Bertil; Svensson Leif; Malihi Reza; Remberger Mats; Uzunel Mehmet; Thörne Anders; Ringdén Olle
Indium-111-labelled donor-lymphocyte infusion by way of hepatic artery and radio-frequency ablation against liver metastases of renal and colon carcinoma after allogeneic hematopoietic stem-cell transplantation.
Transplantation 2004;78(5):697-703.
2004: Le Blanc K; Rasmusson I; Götherström C; Seidel C; Sundberg B; Sundin M; Rosendahl K; Tammik C; Ringdén O
Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes.
Scandinavian journal of immunology 2004;60(3):307-15.
2004: Malm Gunilla; Månsson Jan-Eric; Winiarski Jacek; Mosskin Mikael; Ringdén Olle
Five-year follow-up of two siblings with aspartylglucosaminuria undergoing allogeneic stem-cell transplantation from unrelated donors.
Transplantation 2004;78(3):415-9.
2004: Remberger Mats; Svahn Britt-Marie; Mattsson Jonas; Ringdén Olle
Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation.
Transplantation 2004;78(1):122-7.
2004: Le Blanc Katarina; Rasmusson Ida; Sundberg Berit; Götherström Cecilia; Hassan Moustapha; Uzunel Mehmet; Ringdén Olle
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.
Lancet 2004;363(9419):1439-41.
2004: Grinnemo K H; Månsson A; Dellgren G; Klingberg D; Wardell E; Drvota V; Tammik C; Holgersson J; Ringdén O; Sylvén C; Le Blanc K
Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium.
The Journal of thoracic and cardiovascular surgery 2004;127(5):1293-300.
2004: Svahn B-M; Bjurman B; Myrbäck K-E; Aschan J; Ringdén O
Is it safe to treat allogeneic stem cell transplanted recipients at home during the pancytopenic phase? A pilot trial.
Presse médicale (Paris, France : 1983) 2004;33(7):474-8.
2004: Nordlander Anna; Mattsson Jonas; Ringdén Olle; Leblanc Katarina; Gustafsson Britt; Ljungman Per; Svenberg Petter; Svennilson Johan; Remberger Mats
Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(3):195-203.
2004: Larsson Kajsa; Aschan Johan; Remberger Mats; Ringdén Olle; Winiarski Jacek; Ljungman Per
Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirus.
Transplantation 2004;77(4):526-31.
2004: Ringdén Olle; Schaffer Marie; Le Blanc Katarina; Persson Ulla; Hauzenberger Dan; Abedi Mohammad R; Olerup Olle; Ljungman Per; Remberger Mats
Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(2):128-34.
2004: Ringdén Olle; Labopin Myriam; Gorin Norbert-Claude; Le Blanc Katarina; Rocha Vanderson; Gluckman Eliane; Reiffers Jules; Arcese William; Vossen Jaak M; Jouet Jean-Pierre; Cordonnier Catherine; Frassoni Francesco
Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(3):416-23.
2004: Götherström Cecilia; Ringdén Olle; Tammik Charlotte; Zetterberg Eva; Westgren Magnus; Le Blanc Katarina
Immunologic properties of human fetal mesenchymal stem cells.
American journal of obstetrics and gynecology 2004;190(1):239-45.
2004: Ihendyane N; Sparrelid E; Wretlind B; Remberger M; Andersson J; Ljungman P; Ringdén O; Normark B Henriques; Allen U; Low D E; Norrby-Teglund A
Viridans streptococcal septicaemia in neutropenic patients: role of proinflammatory cytokines.
Bone marrow transplantation 2004;33(1):79-85.
2004: Uzunel M; Ringdén O
Poor correlation of kinetics between BCR-ABL and WT1 transcript levels after allogeneic stem cell transplantation.
Bone marrow transplantation 2004;33(1):47-52.
2003: Ringdén Olle
Novel treatment for refractory acute myeloid leukemia.
Pediatric transplantation 2003;7(6):422-5.
2003: Ringdén Olle; Le Blanc Katarina; Hovatta Outi
Transplantation of embryonic stem cells: possibilities and challenges.
Transplantation 2003;76(7):1011-2.
2003: Rasmusson Ida; Ringdén Olle; Sundberg Berit; Le Blanc Katarina
Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells.
Transplantation 2003;76(8):1208-13.
2003: Le Blanc Katarina; Tammik Charlotte; Rosendahl Kerstin; Zetterberg Eva; Ringdén Olle
HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells.
Experimental hematology 2003;31(10):890-6.
2003: Le Blanc Katarina; Ringdén Olle; Remberger Mats
A low body mass index is correlated with poor survival after allogeneic stem cell transplantation.
Haematologica 2003;88(9):1044-52.
2003: Schaffer M; Aldener-Cannavá A; Remberger M; Ringdén O; Olerup O
Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation.
Tissue antigens 2003;62(3):243-50.
2003: Uzunel Mehmet; Jaksch Marie; Mattsson Jonas; Ringdén Olle
Minimal residual disease detection after allogeneic stem cell transplantation is correlated to relapse in patients with acute lymphoblastic leukaemia.
British journal of haematology 2003;122(5):788-94.
2003: Sjöö F; Aschan J; Barkholt L; Hassan Z; Ringdén O; Hassan M
N-acetyl-L-cysteine does not affect the pharmacokinetics or myelosuppressive effect of busulfan during conditioning prior to allogeneic stem cell transplantation.
Bone marrow transplantation 2003;32(4):349-54.
2003: Götherström C; Ringdén O; Westgren M; Tammik C; Le Blanc K
Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells.
Bone marrow transplantation 2003;32(3):265-72.
2003: Seidel Carina; Ringdén Olle; Remberger Mats
Increased levels of syndecan-1 in serum during acute graft-versus-host disease.
Transplantation 2003;76(2):423-6.
2003: Lindton Bim; Markling Lola; Ringdén Olle; Westgren Magnus
In vitro studies of the role of CD3+ and CD56+ cells in fetal liver cell alloreactivity.
Transplantation 2003;76(1):204-9.
2003: Remberger M; Naseh N; Aschan J; Barkholt L; LeBlanc K; Svennberg P; Ringdén O
G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV.
Bone marrow transplantation 2003;32(2):217-23.
2003: Ringdén Olle; Barrett A John; Zhang Mei-Jie; Loberiza Fausto R; Bolwell Brian J; Cairo Mitchell S; Gale Robert Peter; Hale Gregory A; Litzow Mark R; Martino Rodrigo; Russell James A; Tiberghien Pierre; Urbano-Ispizua Alvaro; Horowitz Mary M
Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses.
British journal of haematology 2003;121(6):874-85.
2003: Söderdahl Gunnar; Barkholt Lisbeth; Hentschke Patrik; Mattsson Jonas; Uzunel Mehmet; Ericzon Bo-Göran; Ringdén Olle
Liver transplantation followed by adjuvant nonmyeloablative hemopoietic stem cell transplantation for advanced primary liver cancer in humans.
Transplantation 2003;75(7):1061-6.
2003: Svennilson Johan; Remberger Mats; Ringdén Olle
Risk factors for moderate-to-severe acute graft-vs.-host disease after allogeneic stem cell transplantation in children.
Pediatric transplantation 2003;7(2):130-6.
2003: Nilsson C; Aschan J; Hentschke P; Ringdén O; Ljungman P; Hassan M
The effect of metronidazole on busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation.
Bone marrow transplantation 2003;31(6):429-35.
2003: Gustafsson Jernberg A; Remberger M; Ringdén O; Winiarski J
Graft-versus-leukaemia effect in children: chronic GVHD has a significant impact on relapse and survival.
Bone marrow transplantation 2003;31(3):175-81.
2003: Hentschke P; Barkholt L; Uzunel M; Mattsson J; Wersäll P; Pisa P; Martola J; Albiin N; Wernerson A; Söderberg M; Remberger M; Thörne A; Ringdén O
Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma.
Bone marrow transplantation 2003;31(4):253-61.
2003: Uzunel Mehmet; Mattsson Jonas; Brune Mats; Johansson Jan-Erik; Aschan Johan; Ringdén Olle
Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation.
Blood 2003;101(2):469-72.
2002: Ringdén O; Labopin M; Bacigalupo A; Arcese W; Schaefer U W; Willemze R; Koc H; Bunjes D; Gluckman E; Rocha V; Schattenberg A; Frassoni F
Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(24):4655-64.
2002: Hassan M; Nilsson C; Hassan Z; Gungor T; Aschan J; Winiarski J; Hentschke P; Ringdén O; Eber S; Seger R; Ljungman P
A phase II trial of liposomal busulphan as an intravenous myeloablative agent prior to stem cell transplantation: 500 mg/m(2) as a optimal total dose for conditioning.
Bone marrow transplantation 2002;30(12):833-41.
2002: Remberger M; Mattsson J; Hentschke P; Aschan J; Barkholt L; Svennilson J; Ljungman P; Ringdén O
The graft-versus-leukaemia effect in haematopoietic stem cell transplantation using unrelated donors.
Bone marrow transplantation 2002;30(11):761-8.
2002: Remberger Mats; Persson Ulla; Hauzenberger Dan; Ringdén Olle
An association between human leucocyte antigen alleles and acute and chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
British journal of haematology 2002;119(3):751-9.
2002: Svahn Britt-Marie; Remberger Mats; Myrbäck Karl-Erik; Holmberg Katarina; Eriksson Britta; Hentschke Patrik; Aschan Johan; Barkholt Lisbeth; Ringdén Olle
Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care.
Blood 2002;100(13):4317-24.
2002: Rocha Vanderson; Labopin Myriam; Gluckman Eliane; Powles Ray; Arcese William; Bacigalupo Andrea; Reiffers Josy; Iriondo Arturo; Ringdén Olle; Ruutu Tapani; Frassoni Francesco;
Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(21):4324-30.
2002: Januszkiewicz A; Loré K; Essén P; Andersson B; McNurlan M A; Garlick P J; Ringdén O; Andersson J; Wernerman J
Response of in vivo protein synthesis in T lymphocytes and leucocytes to an endotoxin challenge in healthy volunteers.
Clinical and experimental immunology 2002;130(2):263-70.
2002: Ruutu Tapani; Eriksson Britta; Remes Kari; Juvonen Eeva; Volin Liisa; Remberger Mats; Parkkali Terttu; Hägglund Hans; Ringdén Olle;
Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation.
Blood 2002;100(6):1977-83.
2002: Carlens S; Liu D; Ringdén O; Aschan J; Christensson B; Levitsky V; Dilber M S
Cytolytic T cell reactivity to Epstein-Barr virus is lost during in vitro T cell expansion.
Journal of hematotherapy & stem cell research 2002;11(4):669-74.
2002: Westgren Magnus; Ringdén Olle; Bartmann Peter; Bui The-Hung; Lindton Bim; Mattsson Jonas; Uzunel Mehmet; Zetterquist Henrik; Hansmann Manfred
Prenatal T-cell reconstitution after in utero transplantation with fetal liver cells in a patient with X-linked severe combined immunodeficiency.
American journal of obstetrics and gynecology 2002;187(2):475-82.
2002: Larsson Kajsa; Lönnqvist B; Ringdén O; Hedquist B; Ljungman P
CMV retinitis after allogeneic bone marrow transplantation: a report of five cases.
Transplant infectious disease : an official journal of the Transplantation Society 2002;4(2):75-9.
2002: Hentschke Patrik; Remberger Mats; Mattsson Jonas; Barkholt Lisbeth; Aschan Johan; Ljungman Per; Ringdén Olle
Clinical tolerance after allogeneic hematopoietic stem cell transplantation: a study of influencing factors.
Transplantation 2002;73(6):930-6.
2002: Remberger M; Storer B; Ringdén O; Anasetti C
Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors.
Bone marrow transplantation 2002;29(5):391-7.
2002: Remberger Mats; Ringdén Olle
Survival after bone-marrow transplantation.
Lancet 2002;359(9309):888.
2002: van Rood Jon J; Loberiza Fausto R; Zhang Mei-Jie; Oudshoorn Machteld; Claas Frans; Cairo Mitchell S; Champlin Richard E; Gale Robert Peter; Ringdén Olle; Hows Jill M; Horowitz Mary H
Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.
Blood 2002;99(5):1572-7.
2002: Lindton Bim; Markling Lola; Ringdén Olle; Westgren Magnus
In vitro studies of haematopoietic colony-forming capacity of human fetal liver cells at exposure to cytotoxic and immunomodulatory drugs.
Fetal diagnosis and therapy 2002;17(2):104-9.
2002: Ringdén Olle
Ten years' experience with liposomal amphotericin B in transplant recipients at Huddinge University Hospital.
The Journal of antimicrobial chemotherapy 2002;49 Suppl 1():51-5.
2002: Remberger Mats; Kumlien Gunilla; Aschan Johan; Barkholt Lisbeth; Hentschke Patrik; Ljungman Per; Mattsson Jonas; Svennilson Johan; Ringdén Olle
Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(12):674-82.
2002: Ljungman Per; Larsson Kajsa; Kumlien Gunilla; Aschan Johan; Barkholt Lisbeth; Gustafsson-Jernberg Asa; Lewensohn-Fuchs Ilona; Ringdén Olle
Leukocyte depleted, unscreened blood products give a low risk for CMV infection and disease in CMV seronegative allogeneic stem cell transplant recipients with seronegative stem cell donors.
Scandinavian journal of infectious diseases 2002;34(5):347-50.
2001: Mattsson J; Uzunel M; Brune M; Hentschke P; Barkholt L; Stierner U; Aschan J; Ringdén O
Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation.
British journal of haematology 2001;115(4):935-44.
2001: Zetterquist H; Hentschke P; Thörne A; Wernerson A; Mattsson J; Uzunel M; Martola J; Albiin N; Aschan J; Papadogiannakis N; Ringdén O
A graft-versus-colonic cancer effect of allogeneic stem cell transplantation.
Bone marrow transplantation 2001;28(12):1161-6.
2001: Mattsson J; Uzunel M; Tammik L; Aschan J; Ringdén O
Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(12):1976-85.
2001: Januszkiewicz A; Essén P; McNurlan M A; Ringdén O; Garlick P J; Wernerman J
A combined stress hormone infusion decreases in vivo protein synthesis in human T lymphocytes in healthy volunteers.
Metabolism: clinical and experimental 2001;50(11):1308-14.
2001: Uzunel M; Mattsson J; Jaksch M; Remberger M; Ringdén O
The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia.
Blood 2001;98(6):1982-4.
2001: Remberger M; Ringdén O; Blau I W; Ottinger H; Kremens B; Kiehl M G; Aschan J; Beelen D W; Basara N; Kumlien G; Fauser A A; Runde V
No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors.
Blood 2001;98(6):1739-45.
2001: Remberger M; Aschan J; Barkholt L; Tollemar J; Ringdén O
Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin.
Clinical transplantation 2001;15(3):147-53.
2001: Januszkiewicz A; Essén P; McNurlan M A; Ringdén O; Garlick P J; Wernerman J
Determination of in vivo protein synthesis in human T lymphocytes.
Clinical nutrition (Edinburgh, Scotland) 2001;20(2):181-2.
2001: Hassan Z; Ljungman P; Ringdén O; Winiarski J; Nilsson C; Aschan J; Whitley H R; Hassan M
Pharmacokinetics of liposomal busulphan in man.
Bone marrow transplantation 2001;27(5):479-85.
2001: Filipovich A H; Stone J V; Tomany S C; Ireland M; Kollman C; Pelz C J; Casper J T; Cowan M J; Edwards J R; Fasth A; Gale R P; Junker A; Kamani N R; Loechelt B J; Pietryga D W; Ringdén O; Vowels M; Hegland J; Williams A V; Klein J P; Sobocinski K A; Rowlings P A; Horowitz M M
Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program.
Blood 2001;97(6):1598-603.
2001: Barkholt L; Hentschke P; Zetterquist H; Mattsson J; Uzunel M; Wersäll P; Martola J; Albin N; Aschan J; Wijkström H; Tillegård A; Oman S; Wernerson A; Niederwieser D; Thörne A; Ringdén O
An allogeneic anti-cancer effect after hematopoietic stem cell transplantation.
Transplantation proceedings 2001;33(1-2):1862-4.
2001: Remberger M; Aschan J; Lönnqvist B; Carlens S; Gustafsson B; Hentschke P; Klaesson S; Mattsson J; Ljungman P; Ringdén O
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation.
Transplantation proceedings 2001;33(1-2):1769-70.
2001: Mattsson J; Uzunel M; Remberger M; Ringdén O
T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation.
Transplantation 2001;71(3):433-9.
2001: Remberger M; Aschan J; Lönnqvist B; Carlens S; Gustafsson B; Hentschke P; Klaesson S; Mattsson J; Ljungman P; Ringdén O
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation.
European journal of haematology 2001;66(1):50-6.
2001: Mattsson J; Uzunel M; Remberger M; Tammik L; Omazic B; Levitsky V; Zou J Z; Hentschke P; Ringdén O
Poor immune reconstitution after four or five major HLA antigens mismatched T cell-depleted allogeneic and autologous stem cell transplantation.
Clinical and experimental immunology 2001;123(1):162-9.
2001: Lindton B; Tolfvenstam T; Norbeck O; Markling L; Ringdén O; Westgren M; Broliden K
Recombinant parvovirus B19 empty capsids inhibit fetal hematopoietic colony formation in vitro.
Fetal diagnosis and therapy 2001;16(1):26-31.
2001: Carlens S; Remberger M; Aschan J; Ringdén O
The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(1):31-8.
2000: Ringdén O; Labopin M; Gorin N C; Schmitz N; Schaefer U W; Prentice H G; Bergmann L; Jouet J P; Mandelli F; Blaise D; Fouillard L; Frassoni F;
Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?
British journal of haematology 2000;111(4):1130-7.
2000: Ljungman P; Wang F Z; Clark D A; Emery V C; Remberger M; Ringdén O; Linde A
High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients.
British journal of haematology 2000;111(3):774-81.
2000: Svahn B M; Bjurman B; Myrbäck K E; Aschan J; Ringdén O
Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trial.
Bone marrow transplantation 2000;26(10):1057-60.
2000: Akesson E; Markling L; Kjaeldgaard A; Falci S; Ringdén O
MHC antigen expression in human first trimester spinal cord with implications for clinical transplantation procedures.
Journal of neuroimmunology 2000;111(1-2):210-4.
2000: Bågesund M; Richter S; Agren B; Ringdén O; Dahllöf G
Scintigraphic study of the major salivary glands in pediatric bone marrow transplant recipients.
Bone marrow transplantation 2000;26(7):775-9.
2000: Hassan M; Svensson J O; Nilsson C; Hentschke P; Al-Shurbaji A; Aschan J; Ljungman P; Ringdén O
Ketobemidone may alter busulfan pharmacokinetics during high-dose therapy.
Therapeutic drug monitoring 2000;22(4):383-5.
2000: Champlin R E; Passweg J R; Zhang M J; Rowlings P A; Pelz C J; Atkinson K A; Barrett A J; Cahn J Y; Drobyski W R; Gale R P; Goldman J M; Gratwohl A; Gordon-Smith E C; Henslee-Downey P J; Herzig R H; Klein J P; Marmont A M; O'Reilly R J; Ringdén O; Slavin S; Sobocinski K A; Speck B; Weiner R S; Horowitz M M
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities.
Blood 2000;95(12):3996-4003.
2000: Champlin R E; Schmitz N; Horowitz M M; Chapuis B; Chopra R; Cornelissen J J; Gale R P; Goldman J M; Loberiza F R; Hertenstein B; Klein J P; Montserrat E; Zhang M J; Ringdén O; Tomany S C; Rowlings P A; Van Hoef M E; Gratwohl A
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).
Blood 2000;95(12):3702-9.
2000: Barrett A J; Ringdén O; Zhang M J; Bashey A; Cahn J Y; Cairo M S; Gale R P; Gratwohl A; Locatelli F; Martino R; Schultz K R; Tiberghien P
Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia.
Blood 2000;95(11):3323-7.
2000: Ringdén O; Remberger M; Runde V; Bornhäuser M; Blau I W; Basara N; Hölig K; Beelen D W; Hägglund H; Basu O; Ehninger G; Fauser A A
Faster engraftment of neutrophils and platelets with peripheral blood stem cells from unrelated donors: a comparison with marrow transplantation.
Bone marrow transplantation 2000;25 Suppl 2():S6-8.
2000: Ringdén O; Söderdahl G; Mattsson J; Uzunel M; Remberger M; Hentschke P; Hägglund H; Sparrelid E; Elmhorn-Rosenborg A; Duraj F; Zetterquist H; Ericzon B G
Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer.
Transplantation 2000;69(10):2043-8.
2000: Ringdén O; Labopin M; Gorin N C; Meloni G; Blaise D; Reiffers J; Carlson K; Fouillard L; Frassoni F
The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Bone marrow transplantation 2000;25(10):1053-8.
2000: Ringdén O; Remberger M; Lehmann S; Hentschke P; Mattsson J; Klaesson S; Aschan J
N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation.
Bone marrow transplantation 2000;25(9):993-6.
2000: Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O
Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia.
Bone marrow transplantation 2000;25(8):843-51.
2000: Lindton B; Markling L; Ringdén O; Kjaeldgaard A; Gustafson O; Westgren M
Mixed lymphocyte culture of human fetal liver cells.
Fetal diagnosis and therapy 2000;15(2):71-8.
2000: Januszkiewicz A; Essén P; McNurlan M A; Ringdén O; Wernerman J; Garlick P J
In vivo protein synthesis of circulating human T lymphocytes does not respond to a cortisol challenge within 24 h.
Acta anaesthesiologica Scandinavica 2000;44(2):202-9.
2000: Mattsson J; Uzunel M; Remberger M; Ljungman P; Kimby E; Ringdén O; Zetterquist H
Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(2):247-54.
2000: Björk I N; Brissac C; Remberger M; Mattsson J; Klaesson S; Ringdén O; Stewart J; Lundkvist I
Long-term persistence of oligoclonal serum IgM repertoires in patients treated with allogeneic bone marrow transplantation (BMT).
Clinical and experimental immunology 2000;119(1):240-9.
1999: Hentschke P; Hägglund H; Mattsson J; Carlens S; Lönnqvist B; Ljungman P; Aschan J; Fredrikson S; Ringdén O
Bilateral subdural haematomas following lumbar puncture in three haematopoietic stem cell transplant recipients.
Bone marrow transplantation 1999;24(9):1033-5.
1999: Hägglund H; Ringdén O; Oman S; Remberger M; Carlens S; Mattsson J
A prospective randomized trial of Filgrastim (r-metHuG-CSF) given at different times after unrelated bone marrow transplantation.
Bone marrow transplantation 1999;24(8):831-6.
1999: Remberger M; Svahn B M; Hentschke P; Löfgren C; Ringdén O
Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation.
Bone marrow transplantation 1999;24(8):823-30.
1999: Carlens S; Aschan J; Remberger M; Dilber M; Ringdén O
Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia.
Bone marrow transplantation 1999;24(6):629-35.
1999: Ringdén O; Remberger M; Runde V; Bornhäuser M; Blau I W; Basara N; Hölig K; Beelen D W; Hägglund H; Basu O; Ehninger G; Fauser A A
Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation.
Blood 1999;94(2):455-64.
1999: Ringdén O; Remberger M; Ruutu T; Nikoskelainen J; Volin L; Vindeløv L; Parkkali T; Lenhoff S; Sallerfors B; Mellander L; Ljungman P; Jacobsen N
Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group.
Blood 1999;93(7):2196-201.
1999: Tollemar J; Gross N; Dolgiras N; Jarstrand C; Ringdén O; Hammarström L
Fungal prophylaxis by reduction of fungal colonization by oral administration of bovine anti-Candida antibodies in bone marrow transplant recipients.
Bone marrow transplantation 1999;23(3):283-90.
1998: Hägglund H; Remberger M; Klaesson S; Lönnqvist B; Ljungman P; Ringdén O
Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation.
Blood 1998;92(12):4568-72.
1998: Ljungman P; Aschan J; Lewensohn-Fuchs I; Carlens S; Larsson K; Lönnqvist B; Mattsson J; Sparrelid E; Winiarski J; Ringdén O
Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients.
Transplantation 1998;66(10):1330-4.
1998: Sparrelid E; Hägglund H; Remberger M; Ringdén O; Lönnqvist B; Ljungman P; Andersson J
Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection.
Bone marrow transplantation 1998;22(8):795-800.
1998: Carlens S; Ringdén O; Remberger M; Lönnqvist B; Hägglund H; Klaesson S; Mattsson J; Svahn B M; Winiarski J; Ljungman P; Aschan J
Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.
Bone marrow transplantation 1998;22(8):755-61.
1998: Ringdén O; Remberger M; Carlens S; Hagglund H; Mattsson J; Aschan J; Lönnqvist B; Klaesson S; Winiarski J; Dalianis T; Olerup O; Sparrelid E; Elmhorn-Rosenborg A; Svahn B M; Ljungman P
Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies.
Transplantation 1998;66(5):620-5.
1998: Ljungman P; Halasz R; Hägglund H; Sönnerborg A; Ringdén O
Detection of hepatitis G virus/GB virus C after allogeneic bone marrow transplantation.
Bone marrow transplantation 1998;22(5):499-501.
1998: Hägglund H; Ringdén O; Remberger M; Lönnqvist B; Sparrelid E; Tammik L; Kumlien G
Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donors, compared to bone marrow.
Bone marrow transplantation 1998;22(2):131-6.
1998: Ringdén O; Runde V; Hägglund H; Basu O; Potter M
Transplantation of peripheral blood progenitor cells from unrelated donors.
Transplantation 1998;66(1):142-3.
1998: Remberger M; Ringdén O; Ljungman P; Hägglund H; Winiarski J; Lönnqvist B; Aschan J
Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation.
Bone marrow transplantation 1998;22(1):73-8.
1998: Ringdén O; Hägglund H; Runde V; Basu O; Kroschinsky F; Stockschläder M; Potter M N
Faster engraftment of peripheral blood progenitor cells compared to bone marrow from unrelated donors.
Bone marrow transplantation 1998;21 Suppl 3():S81-4.
1998: Winiarski J; Mattsson J; Gustafsson A; Wester D; Borgström B; Ringdén O; Ljungman P; Dalianis T
Engraftment and chimerism, particularly of T- and B-cells, in children undergoing allogeneic bone marrow transplantation.
Pediatric transplantation 1998;2(2):150-6.
1998: Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Clinical transplantation 1998;12(2):84-92.
1998: Hägglund H; Ringdén O; Agren B; Wennberg L; Remberger M; Rundquist L; Svahn B M; Aspelin P
Intraosseous compared to intravenous infusion of allogeneic bone marrow.
Bone marrow transplantation 1998;21(4):331-5.
1998: Söderdahl G; Tammik C; Remberger M; Ringdén O
Cadaveric bone marrow and spleen cells for transplantation.
Bone marrow transplantation 1998;21(1):79-84.
1998: Ringdén O; Remberger M; Mattsson J; Aschan J; Carlens S; Hägglund H; Lönnqvist B; Sparrelid E; Ljungman P
Transplantation with unrelated bone marrow in leukaemic patients above 40 years of age.
Bone marrow transplantation 1998;21(1):43-9.
1997: Ljungman P; Hassan M; Békássy A N; Ringdén O; Oberg G
High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients.
Bone marrow transplantation 1997;20(11):909-13.
1997: Ringdén O; Andström E E; Remberger M; Dahllöf G; Svahn B M; Tollemar J
Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation.
Pediatric transplantation 1997;1(2):124-9.
1997: Ljungman P; Hägglund H; Björkstrand B; Lönnqvist B; Ringdén O
Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1997;5(6):485-8.
1997: Carlens S; Ringdén O; Remberger M; Mattsson J; Aschan J; Hägglund H; Ljungman P
Factors affecting risk of relapse and leukemia-free survival in HLA-identical sibling marrow transplant recipients with leukemia.
Transplantation proceedings 1997;29(7):3147-9.
1997: Ringdén O; Remberger M; Mattsson J; Aschan J; Hägglund H; Carlens S; Lönnqvist B; Sparrelid E; Ljungman P
Transplantation with unrelated bone marrow in leukemic patients above 40 years of age.
Transplantation proceedings 1997;29(7):3145-6.
1997: Hägglund H; Winiarski J; Ringdén O; Sparrelid E; Ericzon B G
Successful allogeneic bone marrow transplantation in a 2.5-year-old boy with ongoing cytomegalovirus viremia and severe aplastic anemia after orthotopic liver transplantation for non-A, non-B, non-C hepatitis.
Transplantation 1997;64(8):1207-8.
1997: Dahllöf G; Bågesund M; Remberger M; Ringdén O
Risk factors for salivary dysfunction in children 1 year after bone marrow transplantation.
Oral oncology 1997;33(5):327-31.
1997: Dahllöf G; Bågesund M; Ringdén O
Impact of conditioning regimens on salivary function, caries-associated microorganisms and dental caries in children after bone marrow transplantation. A 4-year longitudinal study.
Bone marrow transplantation 1997;20(6):479-83.
1997: Shanwell A; Kristiansson M; Remberger M; Ringdén O
Generation of cytokines in red cell concentrates during storage is prevented by prestorage white cell reduction.
Transfusion 1997;37(7):678-84.
1997: Sparrelid E; Ljungman P; Ekelöf-Andström E; Aschan J; Ringdén O; Winiarski J; Wåhlin B; Andersson J
Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections.
Bone marrow transplantation 1997;19(9):905-8.
1997: Mattsson J; Ringdén O; Aschan J; Barkholt L; Dalianis T; Hägglund H; Ljungman P; Lönnqvist B; Tollemar J; Winiarski J; Remberger M
A low incidence of grade II to IV acute GVHD, but high mortality from infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate.
Transplantation proceedings 1997;29(1-2):735-6.
1997: Ringdén O; Labopin M; Gluckman E; Reiffers J; Vernant J P; Jouet J P; Harousseau J L; Fiere D; Bacigalupo A; Frassoni F; Gorin N C
Strong antileukemic effect of chronic graft-versus-host disease in allogeneic marrow transplant recipients having acute leukemia treated with methotrexate and cyclosporine. The Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Transplantation proceedings 1997;29(1-2):733-4.
1997: Söderdahl G; Tammik C; Remberger M; Sandberg J; Tufveson G; Tollemar J; Ringdén O
Immune markers and hematopoiesis of cadaveric bone marrow for transplantation.
Transplantation proceedings 1997;29(1-2):714-5.
1997: Ruutu T; Ljungman P; Brinch L; Lenhoff S; Lönnqvist B; Ringdén O; Ruutu P; Volin L; Albrechtsen D; Sallerfors B; Ebeling F; Myllylä G
No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group.
Bone marrow transplantation 1997;19(3):233-6.
1996: Ljungman P; Lawler M; Lönnqvist B; Ringdén O; Shanwell A
Rejection of the second allogeneic graft in a patient with severe aplastic anemia reversed by antilymphocyte globulin and donor lymphocyte infusions.
Bone marrow transplantation 1996;18(6):1179-81.
1996: Ringdén O; Labopin M; Gluckman E; Reiffers J; Vernant J P; Jouet J P; Harrousseau J L; Fiere D; Bacigalupo A; Frassoni F; Gorin N C
Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 1996;18(5):921-9.
1996: Jones D R; Bui T H; Anderson E M; Ek S; Liu D; Ringdén O; Westgren M
In utero haematopoietic stem cell transplantation: current perspectives and future potential.
Bone marrow transplantation 1996;18(5):831-7.
1996: Hágglund H; Ringdén O; Ericzon B G; Duraj F; Ljungman P; Lönnqvist B; Winiarski J; Tydén G
Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator or orthotopic liver transplantation after allogeneic bone marrow transplantation.
Transplantation 1996;62(8):1076-80.
1996: Ek S; Markling L; Ringdén O; Kjeldgaard A; Westgren M
Colony formation of human fetal CD34+ hematopoietic cells.
Fetal diagnosis and therapy 1996;11(5):326-34.
1996: Ek S; Westgren M; Markling L; Kjeldgaard A; Ringdén O
Cytokine stimulation of human fetal hematopoietic cells.
Fetal diagnosis and therapy 1996;11(5):318-25.
1996: Ljungman P; Andersson J; Aschan J; Björkstrand B; Hägglund H; Lönnqvist B; Ringdén O; Winiarski J
Oral ribavirin for prevention of severe liver disease caused by hepatitis C virus during allogeneic bone marrow transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(1):167-9.
1996: Malm G; Ringdén O; Winiarski J; Gröndahl E; Uyebrant P; Eriksson U; Håkansson H; Skjeldal O; Månsson J E
Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow transplantation.
Bone marrow transplantation 1996;17(6):1003-8.
1996: Andström E E; Ringdén O; Remberger M; Svahn B M; Tollemar J
Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients.
Mycoses 1996;39(5-6):185-93.
1996: Klaesson S; Tammik L; Markling L; Lundkvist I; Ringdén O
Inhibition of immunoglobulin production in vitro by IgG and F(ab')2 fragments, but not by the Fc portion.
Scandinavian journal of immunology 1996;43(5):574-82.
1996: Ljungman P; Loré K; Aschan J; Klaesson S; Lewensohn-Fuchs I; Lönnqvist B; Ringdén O; Winiarski J; Ehrnst A
Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients.
Bone marrow transplantation 1996;17(4):583-7.
1996: Winiarski J; Ringdén O; Remberger M; Dalianis T; Ljungman P; Borgström B
Bone marrow transplantation in children using unrelated donors at Huddinge Hospital.
Acta paediatrica (Oslo, Norway : 1992) 1996;85(3):327-35.
1995: Klaesson S; Ringdén O; Markling L; Tammik L
Intravenous immunoglobulin: immune modulatory effects in vitro and clinical effects in allogeneic bone marrow transplant recipients.
Transplantation proceedings 1995;27(6):3536-7.
1995: Sparrelid E; Hägglund H; Remberger M; Ljungman P; Malmborg A S; Winiarski J; Andersson J; Ringdén O
Risk factors for septicemia during aplastic period after allogeneic bone marrow transplantation.
Transplantation proceedings 1995;27(6):3530.
1995: Klaesson S; Ringdén O; Ljungman P; Aschan J; Hägglund H; Winiarski J
Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver?
Transplantation 1995;60(11):1225-30.
1995: Brytting M; Mousavi-Jazi M; Boström L; Larsson M; Lunderberg J; Ljungman P; Ringdén O; Sundqvist V A
Cytomegalovirus DNA in peripheral blood leukocytes and plasma from bone marrow transplant recipients.
Transplantation 1995;60(9):961-5.
1995: Tollemar J; Ringdén O
Lipid formulations of amphotericin B. Less toxicity but at what economic cost?
Drug safety : an international journal of medical toxicology and drug experience 1995;13(4):207-18.
1995: Ljungman P; Johansson N; Aschan J; Glaumann H; Lönnqvist B; Ringdén O; Sparrelid E; Sönnerborg A; Winiarski J; Gahrton G
Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients.
Blood 1995;86(4):1614-8.
1995: Ljungman P; Hassan M; Békássy A N; Ringdén O; Oberg G
Busulfan concentration in relation to permanent alopecia in recipients of bone marrow transplants.
Bone marrow transplantation 1995;15(6):869-71.
1995: Ringdén O; Remberger M; Persson U; Ljungman P; Aldener A; Andström E; Aschan J; Bolme P; Dahllöf G; Dalianis T
Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings.
Bone marrow transplantation 1995;15(4):619-25.
1995: Ringdén O; Groth C G; Erikson A; Granqvist S; Månsson J E; Sparrelid E
Ten years' experience of bone marrow transplantation for Gaucher disease.
Transplantation 1995;59(6):864-70.
1995: Bolme P; Henter J I; Winiarski J; Elinder G; Ljungman P; Lönnerholm G; Ringdén O
Allogeneic bone marrow transplantation for hemophagocytic lymphohistiocytosis in Sweden.
Bone marrow transplantation 1995;15(3):331-5.
1995: Tollemar J; Höckerstedt K; Ericzon B G; Jalanko H; Ringdén O
Prophylaxis with liposomal amphotericin B (AmBisome) prevents fungal infections in liver transplant recipients: long-term results of a randomized, placebo-controlled trial.
Transplantation proceedings 1995;27(1):1195-8.
1995: Tollemar J; Höckerstedt K; Ericzon B G; Jalanko H; Ringdén O
Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study.
Transplantation 1995;59(1):45-50.
1994: Ek S; Westgren M; Pschera H; Seiger A; Sundström E; Bui T H; Ringdén O
Screening of fetal stem cells for infection and cytogenetic abnormalities.
Fetal diagnosis and therapy 1994;9(6):357-61.
1994: Ringdén O; Remberger M; Aschan J; Lungman P; Lönnqvist B; Markling L
Long-term follow-up of a randomized trial comparing T cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.
Transplantation 1994;58(8):887-91.
1994: Ringdén O; Andström E; Remberger M; Svahn B M; Tollemar J
Allergic reactions and other rare side-effects of liposomal amphotericin.
Lancet 1994;344(8930):1156-7.
1994: Ljungman P; Lawler M; Asjö B; Bogdanovic G; Karlsson K; Malm C; McCann S R; Ringdén O; Gahrton G
Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukaemia.
British journal of haematology 1994;88(2):403-5.
1994: Ljungman P; Lewensohn-Fuchs I; Hammarström V; Aschan J; Brandt L; Bolme P; Lönnqvist B; Johansson N; Ringdén O; Gahrton G
Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation.
Blood 1994;84(2):657-63.
1994: Ek S; Ringdén O; Markling L; Westgren M
Immunological capacity of human fetal liver cells.
Bone marrow transplantation 1994;14(1):9-14.
1994: Aschan J; Ringdén O; Andström E; Ljungman P; Lönnqvist B; Remberger M
Individualized prophylaxis against graft-versus-host disease in leukemic marrow transplant recipients.
Bone marrow transplantation 1994;14(1):79-87.
1994: Aschan J; Ringdén O
Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
Clinical transplantation 1994;8(3 Pt 1):258-70.
1994: Ringdén O; Remberger M; Persson U; Ljungman P; Aschan J; Bolme P; Dahllöf G; Dalianis T; Gahrton G; Lönnqvist B
[New facts about bone marrow transplantation. An unrelated donor is as good as a related one]
Läkartidningen 1994;91(26-27):2577-82.
1994: Tollemar J; Höckerstedt K; Ericzon B G; Sundberg B; Ringdén O
Fungal prophylaxis with AmBisome in liver and bone marrow transplant recipients: results of two randomized double-blind studies.
Transplantation proceedings 1994;26(3):1833.
1994: Ringdén O; Ruutu T; Remberger M; Nikoskelainen J; Volin L; Vindeløv L; Parkkali T; Lenhoff S; Sallerfors B; Ljungman P
A randomized trial comparing busulfan vs total body irradiation in allogeneic marrow transplant recipients with hematological malignancies.
Transplantation proceedings 1994;26(3):1831-2.
1994: Klaesson S; Ringdén O; Ljungman P; Lönnqvist B; Wennberg L
Treatment with erythropoietin after allogeneic bone marrow transplantation: a randomized, double-blind study.
Transplantation proceedings 1994;26(3):1827-8.
1994: Aschan J; Ringdén O; Andström E; Ljungman P; Remberger M
Prevention of graft-versus-host disease on an individual basis.
Transplantation proceedings 1994;26(3):1823-4.
1994: Ringdén O; Ruutu T; Remberger M; Nikoskelainen J; Volin L; Vindeløv L; Parkkali T; Lenhoff S; Sallerfors B; Ljungman P
A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group.
Blood 1994;83(9):2723-30.
1994: Dahllöf G; Krekmanova L; Kopp S; Borgström B; Forsberg C M; Ringdén O
Craniomandibular dysfunction in children treated with total-body irradiation and bone marrow transplantation.
Acta odontologica Scandinavica 1994;52(2):99-105.
1994: Klaesson S; Ringdén O; Ljungman P; Lönnqvist B; Wennberg L
Reduced blood transfusions requirements after allogeneic bone marrow transplantation: results of a randomised, double-blind study with high-dose erythropoietin.
Bone marrow transplantation 1994;13(4):397-402.
1994: Ringdén O; Tollemar J; Dahllöf G; Tydén G
High cure rate of invasive fungal infections in immunocompromised children using ambisome.
Transplantation proceedings 1994;26(1):175-7.
1994: Ringdén O; Andström E; Remberger M; Svahn B M; Tollemar J
Safety of liposomal amphotericin B (AmBisome) in 187 transplant recipients treated with cyclosporin.
Bone marrow transplantation 1994;14 Suppl 5():S10-4.
1993: Tollemar J; Ringdén O; Andersson S; Sundberg B; Ljungman P; Tydén G
Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients.
Bone marrow transplantation 1993;12(6):577-82.
1993: Klaesson S; Ringdén O; Markling L; Remberger M; Lundkvist I
Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro.
Scandinavian journal of immunology 1993;38(5):477-84.
1993: Ringdén O
Management of graft-versus-host disease.
European journal of haematology 1993;51(1):1-12.
1993: Aschan J; Ringdén O; Sundberg B; Klaesson S; Ljungman P; Lönnqvist B
Increased risk of relapse in patients with chronic myelogenous leukemia given T-cell depleted marrow compared to methotrexate combined with cyclosporin or monotherapy for the prevention of graft-versus-host disease.
European journal of haematology 1993;50(5):269-74.
1993: Ringdén O; Tollemar J
Liposomal amphotericin B (AmBisome) treatment of invasive fungal infections in immunocompromised children.
Mycoses 1993;36(5-6):187-92.
1993: Ek S; Ringdén O; Markling L; Dahlberg N; Pschera H; Seiger A; Sundström E; Westgren M
Effects of cryopreservation on subsets of fetal liver cells.
Bone marrow transplantation 1993;11(5):395-8.
1993: Tollemar J; Ringdén O; Andersson S; Sundberg B; Ljungman P; Sparrelid E; Tydén G
Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: a randomized trial in bone marrow transplant recipients.
Transplantation proceedings 1993;25(1 Pt 2):1495-7.
1993: Ringdén O
Decreased transplant-related complications and improved leukemia-free survival in adults receiving methotrexate combined with cyclosporin compared with either agent alone for prevention of graft-versus-host disease. Advisory Committee of the International Bone Marrow Transplant Registry.
Transplantation proceedings 1993;25(1 Pt 2):1241-2.
1993: Ljungman P; Aschan J; Azinge J N; Brandt L; Ehrnst A; Hammarström V; Klaesson S; Linde A; Lönnqvist B; Ringdén O
Cytomegalovirus viraemia and specific T-helper cell responses as predictors of disease after allogeneic marrow transplantation.
British journal of haematology 1993;83(1):118-24.
1993: Ek S; Ringdén O; Markling L; Westgren M
Cryopreservation of fetal stem cells.
Bone marrow transplantation 1993;11 Suppl 1():123.
1992: Tollemar J; Andersson S; Ringdén O; Tydén G
A retrospective clinical comparison between antifungal treatment with liposomal amphotericin B (AmBisome) and conventional amphotericin B in transplant recipients.
Mycoses 1992;35(9-10):215-20.
1992: Pihlstedt P; Paulin T; Sundberg B; Nilsson B; Ringdén O
Blood transfusion in marrow graft recipients.
Annals of hematology 1992;65(2):66-70.
1992: Ringdén O; Wennberg L; Ericzon B G; Kallman R; Aström M; Duraj F; Söderdahl G; Tydén G; Groth C G
Alteplase for hepatic veno-occlusive disease after bone marrow transplantation.
Lancet 1992;340(8818):546-7.
1992: Mattsson T; Heimdahl A; Dahllöf G; Lönnquist B; Ringdén O
Oral and nutritional status in allogeneic marrow recipients treated with T-cell depletion or cyclosporine combined with methotrexate to prevent graft-versus-host disease.
Oral surgery, oral medicine, and oral pathology 1992;74(1):34-40.
1992: Ringdén O
Correlation of pretransplant viral serology and complications of bone marrow transplantation.
Annals of hematology 1992;64 Suppl():A143-7.
1992: Westgren M; Bui T M; Ek S; Egberg N; Hagenfelt L; Markling L; Pschera H; Seiger A; Ringdén O
[Intrauterine transplantation with fetal stem cells cures fetal diseases]
Läkartidningen 1992;89(19):1645, 1651.
1992: Tollemar J; Sundberg B; Markling L; Ringdén O
Immune response to Candida before and 5 years after allogeneic bone marrow transplantation.
Transplantation proceedings 1992;24(1):378-9.
1992: Boström L; Ringdén O
No association between splenomegaly and acute graft-vs.-host disease in humans after allogeneic bone marrow transplantation.
Transplantation proceedings 1992;24(1):374-5.
1992: Tibell A; Ringdén O; Sundberg B
Cyclosporine A in fat emulsion carrier: immunosuppressive effect in vitro.
Scandinavian journal of immunology 1992;35(2):231-6.
1992: Boström L; Ringdén O; Forsgren M
Strong donor mononuclear cell reactivity for herpes simplex virus antigen in immune donor/recipient pairs is associated with acute graft-versus-host disease.
Transplantation proceedings 1992;24(1):376-7.
1992: Ringdén O
Allogeneic bone marrow transplantation: the Huddinge experience.
Transplantation proceedings 1992;24(1):371-3.
1992: Mattsson T; Arvidson K; Heimdahl A; Ljungman P; Dahllof G; Ringdén O
Alterations in taste acuity associated with allogeneic bone marrow transplantation.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1992;21(1):33-7.
1992: Ringdén O; Klaesson S; Sundberg B; Ljungman P; Lönnqvist B; Persson U
Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin compared with monotherapy in recipients of bone marrow from donors other than HLA identical siblings.
Bone marrow transplantation 1992;9(1):19-25.
1992: Mattsson T; Sundqvist K G; Heimdahl A; Dahllöf G; Ljungman P; Ringdén O
A comparative immunological analysis of the oral mucosa in chronic graft-versus-host disease and oral lichen planus.
Archives of oral biology 1992;37(7):539-47.
1992: Aschan J; Ringdén O; Ljungman P; Lönnqvist B; Ohlman S
Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients.
Scandinavian journal of infectious diseases 1992;24(2):143-50.
1991: Duraj F F; Bäckman L; Dati F; Ringdén O
Serum levels of alpha-1 microglobulin and beta-2 microglobulin in bone marrow transplant recipients treated with cyclosporin A.
Transplant international : official journal of the European Society for Organ Transplantation 1991;4(3):146-50.
1991: Boström L; Ringdén O; Forsgren M
Strong donor mononuclear cell reactivity for herpes simplex virus (HSV) antigen in HSV immune donors combined with recipient seropositivity for HSV is associated with acute graft-versus-host disease.
Scandinavian journal of immunology 1991;34(1):45-52.
1991: Ljungman P; Aschan J; Bolme P; Lindqvist R; Lönnqvist B; Ringdén O; Winiarski J; Gahrton G
[Bone marrow transplantation or antithymocyte globulin in aplastic anemia? Both therapeutic alternatives result in good quality of life]
Läkartidningen 1991;88(25):2308-11.
1991: Brattström C; Tollemar J; Ringdén O; Bergström K; Tydén G
Isoamylase levels in bone marrow transplant patients are affected by total body irradiation and not by graft-versus-host disease.
Transplant international : official journal of the European Society for Organ Transplantation 1991;4(2):96-8.
1991: Mattsson T; Heimdahl A; Dahllof G; Nilsson B; Lonnqvist B; Ringdén O
Variables predicting oral mucosal lesions in allogenic bone marrow recipients.
Head & neck 1991;13(3):224-9.
1991: Tollemar J; Ringdén O
Early recovery of lymphocyte response to Candida after bone marrow transplantation in colonized patients.
Bone marrow transplantation 1991;7(4):285-91.
1991: Ringdén O; Pihlstedt P; Markling L; Aschan J; Båryd I; Ljungman P; Lönnqvist B; Tollemar J; Janossy G; Sundberg B
Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients.
Bone marrow transplantation 1991;7(3):221-6.
1991: Aschan J; Ringdén O; Sundberg B; Gahrton G; Ljungman P; Winiarski J
Methotrexate combined with cyclosporin A decreases graft-versus-host disease, but increases leukemic relapse compared to monotherapy.
Bone marrow transplantation 1991;7(2):113-9.
1991: Dahllöf G; Forsberg C M; Näsman M; Mattsson T; Modéer T; Borgström B; Bolme P; Ringdén O
Craniofacial growth in bone marrow transplant recipients treated with growth hormone after total body irradiation.
Scandinavian journal of dental research 1991;99(1):44-7.
1991: Tollemar J; Sundberg B; Markling L; Ringdén O
Immunological response in vitro by Candida after allogeneic bone marrow transplantation.
Bone marrow transplantation 1991;7 Suppl 2():48.
1990: Abedi M R; Hammarström L; Ringdén O; Smith C I
Development of IgA deficiency after bone marrow transplantation. The influence of acute and chronic graft-versus-host disease.
Transplantation 1990;50(3):415-21.
1990: Abedi M R; Bäckman L; Boström L; Lindbäck B; Ringdén O
Markedly increased serum erythropoietin levels following conditioning for allogeneic bone marrow transplantation.
Bone marrow transplantation 1990;6(2):121-6.
1990: Ljungman P; Wiklund-Hammarsten M; Duraj V; Hammarström L; Lönnqvist B; Paulin T; Ringdén O; Pepe M S; Gahrton G
Response to tetanus toxoid immunization after allogeneic bone marrow transplantation.
The Journal of infectious diseases 1990;162(2):496-500.
1990: Tollemar J; Ericzon B G; Barkholt L; Andersson J; Ringdén O; Groth C G
Risk factors for deep candida infections in liver transplant recipients.
Transplantation proceedings 1990;22(4):1826-7.
1990: Mattsson T; Heimdahl A; Dahllöf G; Lönnquist B; Ringdén O
Predisposing factors for development of oral lesions after allogeneic bone marrow transplantation.
Transplantation proceedings 1990;22(1):210.
1990: Tollemar J; Ringdén O; Aschan J; Sundberg B
Which bone marrow transplant recipients are at risk of acquiring life-threatening fungal infections?
Transplantation proceedings 1990;22(1):208-9.
1990: Abedi M R; Bäckman L; Boström L; Lindbäck B; Ringdén O
Serum erythropoietin levels after bone marrow transplantation.
Transplantation proceedings 1990;22(1):205.
1990: Ringdén O; Groth C G; Aschan J; Bolme P; Ljungman P; Lönnqvist B; Malm G; Månsson J E; Shanwell A; Svennerholm L
Bone marrow transplantation for metabolic disorders at Huddinge Hospital.
Transplantation proceedings 1990;22(1):198-202.
1990: Aschan J; Ringdén O; Tollemar J; Ljungman P; Lönnqvist B; Pihlstedt P; Markling L; Sundberg B
Improved survival in marrow recipients above 30 years of age with better prevention of graft-versus-host disease.
Transplantation proceedings 1990;22(1):195-7.
1990: Duraj F F; Bäckman L; Dati F; Ringdén O
Monitoring low molecular weight serum proteins in cyclosporine A-treated bone marrow transplant recipients.
Transplantation proceedings 1990;22(1):203-4.
1990: Ringdén O; Aschan J; Boström L; Dahllöf G; Tollemar J; Paulin T; Gahrton G; Groth C G; Klaesson S; Lindquist R
Allogeneic bone marrow transplantations at Huddinge Hospital and strategies to improve survival.
Clinical transplants 1990;():175-87.
1989: Heimdahl A; Mattsson T; Dahllöf G; Lönnquist B; Ringdén O
The oral cavity as a port of entry for early infections in patients treated with bone marrow transplantation.
Oral surgery, oral medicine, and oral pathology 1989;68(6):711-6.
1989: Laurenzi M A; Persson M A; Dalsgaard C J; Ringdén O
Stimulation of human B lymphocyte differentiation by the neuropeptides substance P and neurokinin A.
Scandinavian journal of immunology 1989;30(6):695-701.
1989: Dahllöf G; Forsberg C M; Ringdén O; Bolme P; Borgström B; Näsman M; Heimdahl A; Modéer T
Facial growth and morphology in long-term survivors after bone marrow transplantation.
European journal of orthodontics 1989;11(4):332-40.
1989: Tollemar J; Ringdén O; Boström L; Nilsson B; Sundberg B
Variables predicting deep fungal infections in bone marrow transplant recipients.
Bone marrow transplantation 1989;4(6):635-41.
1989: Tollemar J; Ringdén O; Holmberg K
Candida albicans: mannan and protein activation of cells from various human lymphoid organs.
Scandinavian journal of immunology 1989;30(4):473-80.
1989: Boström L; Ringdén O; Sundberg B; Ljungman P; Linde A; Nilsson B
Pretransplant herpes virus serology and chronic graft-versus-host disease.
Bone marrow transplantation 1989;4(5):547-52.
1989: Dahllöf G; Heimdahl A; Modéer T; Twetman S; Bolme P; Ringdén O
Oral mucous membrane lesions in children treated with bone marrow transplantation.
Scandinavian journal of dental research 1989;97(3):268-77.
1989: Abedi M R; Bäckman L; Persson U; Ringdén O
Serum IgE levels after bone marrow transplantation.
Bone marrow transplantation 1989;4(3):255-60.
1989: Ljungman P; Fridell E; Lönnqvist B; Bolme P; Böttiger M; Gahrton G; Linde A; Ringdén O; Wahren B
Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.
The Journal of infectious diseases 1989;159(4):610-5.
1989: Bäckman L; Ringdén O; Dati F
Serum levels of alpha-1 microglobulin in recipients of renal allografts.
Transplant international : official journal of the European Society for Organ Transplantation 1989;2(1):23-6.
1989: Bäckman L; Appelkvist E L; Ringdén O; Dallner G
Urinary levels of basic glutathione transferase as an indicator of proximal tubular damage in renal transplant recipients.
Transplantation proceedings 1989;21(1 Pt 2):1514-6.
1989: Tollemar J; Ringdén O; Bäckman L; Janossy G; Lönnqvist B; Markling L; Philstedt P; Sundberg B
Results of four different protocols for prophylaxis against graft-versus-host disease.
Transplantation proceedings 1989;21(1 Pt 3):3008-10.
1989: Ringdén O; Horowitz M M
Graft-versus-leukemia reactions in humans. The Advisory Committee of the International Bone Marrow Transplant Registry.
Transplantation proceedings 1989;21(1 Pt 3):2989-92.
1989: Ringdén O
Immunodeficiency associated with bone marrow transplantation.
Current opinion in immunology 1989;1(3):497-501.
1989: Duraj F; Bäckman L; Dati F; Ringdén O
Serum alpha-1 microglobulin levels as indicators of renal function in allograft recipients.
Transplantation proceedings 1989;21(1 Pt 2):1871-2.
1989: Bäckman L; Ringdén O
The neopterin/creatinine ratio cannot be used to diagnose rejection episodes in renal transplant recipients.
Nephron 1989;53(3):287.
1989: Ringdén O; Bolme P; Lönnqvist B; Gustafsson G; Kreuger A
Allogeneic bone marrow transplantation versus chemotherapy in children with acute leukemia in Sweden.
Pediatric hematology and oncology 1989;6(2):137-44.
1989: Aschan J; Ringdén O; Ljungman P; Andersson J; Lewensohn-Fuchs I; Forsgren M
Influenza B in transplant patients.
Scandinavian journal of infectious diseases 1989;21(3):349-50.
1989: Tollemar J; Holmberg K; Ringdén O; Lönnqvist B
Surveillance tests for the diagnosis of invasive fungal infections in bone marrow transplant recipients.
Scandinavian journal of infectious diseases 1989;21(2):205-12.
1988: Smith C I; Norberg R; Isenberg D; Staines N A; Gahrton G; Ringdén O; Hammarström L
Anti-DNA antibody synthesis after bone marrow transplantation: implications for IgG subclass restrictivity and pathogenicity of autoantibodies.
Bone marrow transplantation 1988;3(6):583-8.
1988: Boström L; Ringdén O; Sundberg B; Linde A; Tollemar J; Nilsson B
Pretransplant herpesvirus serology and acute graft-versus-host disease.
Transplantation 1988;46(4):548-52.
1988: Bäckman L; Ringdén O; Tollemar J; Lönnqvist B
An increased risk of relapse in cyclosporin-treated compared with methotrexate-treated patients: long-term follow-up of a randomized trial.
Bone marrow transplantation 1988;3(5):463-71.
1988: Paulin T; Ringdén O; Wahren R
Cytomegalovirus-infected adherent cells interact synergistically and antagonistically with Staphylococcus aureus protein A in vitro.
Scandinavian journal of immunology 1988;28(2):177-84.
1988: Ringdén O; Groth C G; Erikson A; Bäckman L; Granqvist S; Månsson J E; Svennerholm L
Long-term follow-up of the first successful bone marrow transplantation in Gaucher disease.
Transplantation 1988;46(1):66-70.
1988: Ringdén O; Sundberg B; Lönnqvist B; Tollemar J; Gahrton G; Nilsson B
Allogeneic bone marrow transplantation for leukemia: factors of importance for long-term survival and relapse.
Bone marrow transplantation 1988;3(4):281-90.
1988: Tollemar J; Ringdén O; Sundberg B; Bolme P; Brattström C; Gahrton G; Johansen L; Lönnqvist B
Decreased incidence of graft-versus-host disease in bone marrow transplantation recipients treated with a combination of cyclosporine and methotrexate.
Transplantation proceedings 1988;20(3):494-8.
1988: Tollemar J; Ringdén O; Heimdahl A; Lönnqvist B; Sundberg B
Decreased incidence and severity of graft-versus-host disease in HLA matched and mismatched marrow recipients of cyclosporine and methotrexate.
Transplantation proceedings 1988;20(3 Suppl 3):470-9.
1988: Tollemar J; Ringdén O; Holmberg K; Lönnqvist B
Serologic surveillance for evidence of deep disseminating fungal infections in bone marrow transplantation recipients.
Transplantation proceedings 1988;20(3):501-2.
1988: Ringdén O; Bolme P; Lönnqvist B; Tollemar J; Borgström B; Dohlhöf G; Lundgren G; Winiarski J; Gahrton G; Groth C G
Allogeneic bone marrow transplantation in children at Huddinge Hospital.
Transplantation proceedings 1988;20(3):487-90.
1988: Bäckman L; Appelkvist E L; Ringdén O; Dallner G
Appearance of basic glutathione transferase in the urine during tubular complications in renal transplant recipients.
Transplantation proceedings 1988;20(3):427-30.
1988: Ringdén O; Markling L; Sundberg B; Tollemar J
Spontaneous antibody secretion and DNA synthesis in blood lymphocytes increase during acute graft-versus-host disease.
Transplantation proceedings 1988;20(3):503-5.
1988: Bäckman L; Appelkvist E L; Ringdén O; Dallner G
Effects of cyclosporine A on hepatic protein synthesis.
Transplantation proceedings 1988;20(3 Suppl 3):853-8.
1988: Bäckman L; Ringdén O; Björkhem I
Monitoring of serum beta 2 microglobulin and neopterin levels in renal transplant recipients: increased values during impaired renal function and cytomegalovirus infection.
Transplantation proceedings 1988;20(3):410-2.
1988: Bäckman L; Brandt I; Dallner G; Ringdén O
Tissue distribution of [3H]cyclosporine A in mice.
Transplantation proceedings 1988;20(2 Suppl 2):684-91.
1987: Ringdén O; Sundberg B; Markling L; Tollemar J
Polyclonal antibody secretion during acute graft-versus-host disease.
Scandinavian journal of immunology 1987;26(5):469-76.
1987: Ringdén O; Pihlstedt P; Volin L; Nikoskelainen J; Lönnqvist B; Ruutu P; Ruutu T; Toivanen A; Wahren B
Failure to prevent cytomegalovirus infection by cytomegalovirus hyperimmune plasma: a randomized trial by the Nordic Bone Marrow Transplantation Group.
Bone marrow transplantation 1987;2(3):299-305.
1987: Ringdén O
DNA synthesis in human blood mononuclear cells correlates with severity of acute graft-versus-host disease.
Bone marrow transplantation 1987;2(3):259-69.
1987: Ost L; Lönnqvist B; Eriksson L; Ljungman P; Ringdén O
Hemorrhagic cystitis--a manifestation of graft versus host disease?
Bone marrow transplantation 1987;2(1):19-25.
1987: Paulin T; Ringdén O; Nilsson B
Immunological recovery after bone marrow transplantation: role of age, graft-versus-host disease, prednisolone treatment and infections.
Bone marrow transplantation 1987;1(3):317-28.
1987: Groth C G; Fehrman I; Ringdén O; Lundgren G
Related donor kidney transplantation is the best form of treatment for uremia.
Transplantation proceedings 1987;19(1 Pt 3):2278-9.
1986: Ljungman P; Wilczek H; Gahrton G; Gustavsson A; Lundgren G; Lönnqvist B; Ringdén O; Wahren B
Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro.
Bone marrow transplantation 1986;1(2):185-92.
1986: Ringdén O; Paulin T; Sundqvist V A; Wahren B; Pihlstedt P
Induction of immunoglobulin secretion and DNA synthesis in human lymphocytes in vitro by cytomegalovirus preparations.
Scandinavian journal of immunology 1986;24(3):273-81.
1986: Ringdén O; Bäckman L; Lönnqvist B; Heimdahl A; Lindholm A; Bolme P; Gahrton G
A randomized trial comparing use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematological malignancies.
Bone marrow transplantation 1986;1(1):41-51.
1984: Ringdén O; Paulin T; Pihlstedt P; Lönnqvist B; Wahren B
Cytomegalovirus antibody screening of blood donors for immunocompromised seronegative patients.
Lancet 1984;2(8410):1044.
1982: Ringdén O; Lönnqvist B; Lundgren G; Gahrton G; Groth C G; Möller E; Båryd I; Johansson B; Pihlstedt P; Gullbring B
Experience with a cooperative bone marrow transplantation program in Stockholm.
Transplantation 1982;33(5):500-4.
1980: Kunori T; Ringdén O
Antibody secretion and DNA synthesis induced by lipopolysaccharide in enriched human lymphocyte subpopulations.
Scandinavian journal of immunology 1980;11(2):137-45.
1980: Ringdén O
Activation of human T and B cells by rabbit anti-human beta 2-microglobulin.
Scandinavian journal of immunology 1980;11(2):121-30.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Olle Ringdén

Research Profile (preview)

Disorders

Procedures

Living Beings

Concepts & Ideas

Phenomena

Anatomy

Chemicals & Drugs

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Olle Ringdén (preview)

All Publications